Dissemination Of Lung Cancer Screening Education Through Tobacco Quitlines

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07720141
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • High-touch strategy — BEHAVIORAL
    Participants will receive the LCS educational materials, decision coaching call for the SDM visit, and navigation for LCS.

Study Details

The goal of this research study is to compare two different ways to increase lung cancer screening rates for tobacco quitline clients.

Key Dates

First listed
Jul 22, 2026
Start date
Jan 1, 2027
Status verified
Jul 2026
Primary completion
Jun 30, 2032
Completion
Jun 30, 2034

Study Design

Enrollment
650 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: CMP: Comparator - Low-Touch Strategy (Usual Practice): LCS Educational Resources
    Investigators will use a parallel randomized controlled trial to compare a high-touch strategy (emailing/texting + decision coaching + navigation) to a low-touch strategy (emailing/texting) to distribute evidence based LCS educational resources to increase awareness and demand for LCS among quitline clients.
  • Experimental: INT: Intervention - High-Touch Strategy: LCS Educational Resources, Decision Coaching, Navigation
    Investigators will use a parallel randomized controlled trial to compare a high-touch strategy (emailing/texting + decision coaching + navigation) to a low-touch strategy (emailing/texting) to distribute evidence based LCS educational resources to increase awareness and demand for LCS among quitline clients.

Primary Outcome Measure

Safety and Adverse Events (AEs) [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UT MD AndersonHoustonTexas77030
Lisa Lowenstein, PHD
[email protected]
713-792-5807
Lisa Lowenstein, PHD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
UT MD Anderson· Houston, TX

Related Studies